‘Wait, What Do They Do?’ Mizuho Starts Upstart at Underperform, Expects ‘More Pain’ By Investing.com

© Reuters. By Senad Karaahmetovic  Mizuho analysts initiated research coverage on Upstart (NASDAQ:) with an Underperform rating and a $17 per share price target, signaling a downside potential of about 20%. The analysts expect “more pain in coming quarters” after UPST shares fell 95% from the peak. The company’s CEO Dave Girouard said earlier this … Read more

Asia Stocks Sink Fearing U.S. CPI Pain, China COVID Spike

By Ambar Warrick  Investing.com– Asian stock markets retreated for a fourth consecutive session on Thursday as investors feared a potential shock from U.S. inflation data, while rising COVID-19 cases in China drove concerns over renewed lockdown measures.  China’s bluechip index fell 0.7%, while the index shed 0.2%. Concerns over new COVID-related restrictions came back to the … Read more

Fed Set to Reveal ‘Pain’ Coming in Next Stage of Inflation Fight

(Bloomberg) — Federal Reserve officials are about to put numbers on the “pain” they’ve been warning of in recent weeks when they publish new projections for the economy, which could show a substantial rise in interest rates and unemployment ahead as the estimated price tag for reducing inflation. The US central bank will release its … Read more

KeyBanc Upgrades Homebuilders – Early Pain Equals Early Gain By Investing.com

© Reuters. By Sam Boughedda A KeyBanc Capital Markets analyst upgraded the firm’s stance on homebuilders to Overweight from Underweight based on their “Early Pain = Early Gain” thesis. He told investors in a research note that, on balance, they see fundamental and rate pressure persisting but positive relative performance, supporting their upgrades. Shares of … Read more